Contrasting Testosterone Concentrations in Type 1 and Type 2 Diabetes
Open Access
- 1 May 2006
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 29 (5), 1120-1122
- https://doi.org/10.2337/diacare.2951120
Abstract
Fifty patients with type 1 diabetes (age range 23–58 years) and 50 age-matched patients with type 2 diabetes (age range 28–51 years) were included in the study. Patients with known history of hypogonadism, panhypopituitarism, or chronic debilitating disease such as renal failure, cirrhosis, or HIV infection were excluded from the study. Fasting blood samples were obtained from the patients, and total testosterone (TT), free testosterone (FT), sex hormone–binding globulin (SHBG), leutinizing hormone (LH), and follicle-stimulating hormone (FSH) were measured as previously described (1). FT and bioavailable testosterone (bioT) were calculated from SHBG and TT as previously described (1). Hypogonadism was defined as low FT or low calculated FT (2). Mann-Whitney rank-sum test or Student’s t test for unpaired data, χ2 test, and Spearman’s test were used as appropriate (Sigmastat software).Keywords
This publication has 6 references indexed in Scilit:
- Metabolic Syndrome in Type 1 DiabetesDiabetes Care, 2005
- Cortisol, Testosterone, and Coronary Heart DiseaseCirculation, 2005
- Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 DiabetesJournal of Clinical Endocrinology & Metabolism, 2004
- Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivoJournal of Clinical Endocrinology & Metabolism, 1995
- Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese menJournal of Clinical Endocrinology & Metabolism, 1995
- Inhibition of Sex Hormone-Binding Globulin Production in the Human Hepatoma (Hep G2) Cell Line by Insulin and Prolactin*Journal of Clinical Endocrinology & Metabolism, 1988